Covid waves, Gene therapy for haemophilia B, New uses for old drugs

Covid waves, Gene therapy for haemophilia B, ...

Suivant

Should all babies have their genome sequenced at birth?

This week we’re looking at government plans to start sequencing the DNA of every newborn baby in England within the next decade. Each newborn would undergo whole genome sequencing to assess their risk of hundreds of diseases, under NHS plans.It promises a revolution in spotting d ...  Afficher plus

Where does air pollution go inside our body?

James Gallagher stands by four lanes of traffic and inhales exhaust fumes all to see if he can see air pollution in his body. He looks at an intriguing finding that an mRNA vaccine might benefit people being treated with immunotherapy for some cancers and could we be on the cusp ...  Afficher plus

Épisodes Recommandés

The silence of the genes
Discovery

In summer of 2019 NICE approved the use of a completely new class of drugs: the gene silencers. These compounds are transforming the lives of families who have rare debilitating – and sometimes fatal - diseases such as amyloidosis and porphyria. James Gallagher, BBC Health and Sc ...  Afficher plus

Prognosis, a New Show From Bloomberg
Prognosis: Misconception

Where does a medical cure come from? 100 years ago, it wasn't uncommon for scientists to test medicines by taking a dose themselves. As medical technologies get cheaper and more accessible, patients and DIY tinkerers are trying something similar—and mainstream medicine is racing ...  Afficher plus

Talk Evidence - GP data, excess mortality and FDA approval
Medicine and Science from The BMJ

In this Talk Evidence, Helen Macdonald, Joe Ross and Duncan Jarvies discuss what's going on in the world of EBM. Firstly, a while ago on the podcast, we concluded that excess mortality would be the best way to measure the impact of the pandemic - and now a new paper looks at dif ...  Afficher plus

Old Drugs, New Disease
Chasing Life

As medical professionals search for new treatments to help Covid-19 patients, some researchers are taking a second look at drugs that have already been approved by the FDA. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to Dr. David Fajgenbaum about repurposing old drugs ...  Afficher plus